Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00132314. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CSP #555 - Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
In the proposed study 450 veterans with a primary diagnosis of schizophrenia who had at least one psychiatric hospitalization for schizophrenia in the previous 2 years would be randomly assigned at 16 VA medical centers to long-acting injectable risperidone or doctor's choice of oral antipsychotic medication (i.e., excluding other long-acting injectable medications, but not specifying any particular oral agents or dosages). Recruitment would take 27 months to complete, and the study would continue for a third year to allow 9 months of follow-up for the last patient recruited. All patients would be treated from the time of entry up to the end of the three-year study period. Follow-up assessments would continue quarterly. Treatments would not be blinded since giving placebo injections to the comparison group would interfere with the goal of comparing the acceptability of two different methods of medication administration. However, end points will be blindly rated.
Study identification
- NCT ID
- NCT00132314
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 382 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2006 (Type not available)
- Primary completion
- Sep 2009 (Actual)
- Completion
- Sep 2009 (Actual)
- Last update posted
- Dec 20, 2013
2006 – 2009
United States locations
- U.S. sites
- 19
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| VA Medical Center, Tuscaloosa | Tuscaloosa | Alabama | 35404 | — |
| VA Medical Center, Long Beach | Long Beach | California | 90822 | — |
| VA Palo Alto Health Care System | Palo Alto | California | 94304-1290 | — |
| VA Connecticut Health Care System (West Haven) | West Haven | Connecticut | 06516 | — |
| VA Medical Center, Miami | Miami | Florida | 33125 | — |
| VA Medical Center, Augusta | Augusta | Georgia | 30904 | — |
| Jesse Brown VAMC (WestSide Division) | Chicago | Illinois | 60612 | — |
| VA Medical Center, Jamaica Plain Campus | Boston | Massachusetts | 02130 | — |
| John D. Dingell VA Medical Center, Detroit | Detroit | Michigan | 48201 | — |
| VA Medical Center, Minneapolis | Minneapolis | Minnesota | 55417 | — |
| VA Medical Center, Kansas City MO | Kansas City | Missouri | 64128 | — |
| VA Medical Center, Omaha | Omaha | Nebraska | 68105-1873 | — |
| New Mexico VA Health Care System, Albuquerque | Albuquerque | New Mexico | 87108-5153 | — |
| New York Harbor HCS | New York | New York | 10010 | — |
| VA Medical Center, Cleveland | Cleveland | Ohio | 44106 | — |
| VA Medical Center, Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Michael E. DeBakey VA Medical Center (152) | Houston | Texas | 77030 | — |
| Central Texas Veterans Health Care System - Waco | Waco | Texas | 76711 | — |
| VA Puget Sound Health Care System, Seattle | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00132314, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 20, 2013 · Synced Nov 15, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.